SIVEXTRO

Merck Sharp & Dohme LLC🇺🇸 United States

FDA Page

Effective Date: Mar 10, 2023
Approval ID: 75672079-589f-451a-bdbf-eaebcfcc80a9
Products: 2 registered
Version: 28

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SIVEXTRO safely and effectively. See full prescribing information for SIVEXTRO. SIVEXTRO (tedizolid phosphate) for injection, for intravenous use SIVEXTRO (tedizolid phosphate) tablet, for oral use Initial U.S. Approval: 2014

Quick Stats

Total Products2

Labelers2

Label Sections25

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.